LekoskopLekoskop
EN All changes
Medicine recalls and shortages › New approvals › 1 May 2026
MHRA approval

Linerixibat (Lynavoy)

Published on 1 May 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
As with all medicines, we will continue to closely monitor the safety and effectiveness of linerixibat as it is used more widely.
MHRA announcement ↗ All events: Linerixibat (Lynavoy)

What this means

The MHRA has announced the approval of a medicine or a new indication in the UK. Approval does not mean the product is already available on the NHS: NICE appraisal and commissioning may follow.

Summary

As with all medicines, we will continue to closely monitor the safety and effectiveness of linerixibat as it is used more widely.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.